Immune Side Effects May Signal Stronger Tumor Shrinkage and Longer Survival in Gastric Cancer
A Japanese study found that immune-related adverse events during checkpoint inhibitor therapy for advanced gastric cancer were independently linked to ...
A Japanese study found that immune-related adverse events during checkpoint inhibitor therapy for advanced gastric cancer were independently linked to ...
Five-year results from the KEYNOTE-826 trial confirm that adding pembrolizumab to first-line chemotherapy delivers durable survival benefit for patients with ...
A prospective study of 142 patients finds that elevated baseline CEA independently predicts shorter survival in men with metastatic castration-resistant ...
A real-world study of 55 patients with advanced ROS1-rearranged non-small cell lung cancer shows that fusion subtype, PD-L1 expression and ...
The Phase III LONESTAR trial found that adding radiation or surgery after nivolumab plus ipilimumab did not improve survival in ...
A large Japanese multicenter cohort study finds that patients with metastatic gastrointestinal stromal tumors survive significantly longer when metastases appear ...
A retrospective study of 185 glioblastoma patients finds that walking ability measured at hospital discharge independently predicts overall survival beyond ...
Preoperative urinary metabolites may improve survival prediction in colorectal cancer beyond tumor stage, according to a ColoCare study that identified ...
A systematic review of 542 patients finds ruxolitinib-based regimens achieve an 87.2 percent overall response rate in hemophagocytic lymphohistiocytosis, with ...
A network meta-analysis of 28 randomized trials finds that internal radiation and brachytherapy approaches, including iodine-125 brachytherapy, IMRT, and iodine-131-metuximab, ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine